Transgenic plants as medicine production systems

Folia Pharmacologica Japonica

Volumn 110, Issue SUPPL. 1, 1997, Pages 1-6

  Okada, Yoshimi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Antibody; Antigen; Edible vaccine; Molecular farming; Transgenic plant

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALIN; EPITOPE; HEMOGLOBIN; HUMAN SERUM ALBUMIN; MONOCLONAL ANTIBODY; PLANT EXTRACT; RECOMBINANT PROTEIN; TRICHOSANTHIN; VIRUS ANTIGEN; VIRUS VACCINE; VIRUS VECTOR;

ARTICLE; DRUG FORMULATION; DRUG RESEARCH; HIGHER PLANT; NONHUMAN; PHYTOCHEMISTRY; PROTEIN SYNTHESIS; TRANSGENE; VACCINE PRODUCTION;

EID: 0030665049     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.110.supplement_1     Document Type: Article

References (23)

1. Sinmons PC, Dekker BMM, Schrammeijer B, Verwoerd TS, van den Elzen PJM and Hoekema A: Production of correctly processed human serum albumin in transgenic plants. Bio/ Technology 8, 217-221 (1990)
2. Dieryck W, Pagnier J, Poyart C, Marden MC, Gruber V, Bournat P, Baudino S and Merot B: Human haemoglobin from transgenic tobacco. Nature 386, 29-30 (1997)
3. Vanderkerckhove J, Van Damme J, Van Lijsebettens M, Votterman J. De Block M, Vandewiele M, De Clercq A, Van Montagu M and Krebbers E: Enkephalins produced in transgenic plant using modified 2S seed storage protein. Bio/Technology 7, 929-932 (1997)
4. Takamatsu N, Watanabe Y, Yanagi H, Meshi T, Shiba T and Okada Y: Production of enkephalin in tobacco protoplasts using tobacco mosaic virus RNA vector. FEBS Lett 269, 73-76 (1990)
5. Kumagai MH, Turpen TH, Weinzettl N, Della-Cioppa G, Turpen AM, Donson J, Hiff ME, Grantham GL, Dawson WO, Chow TP, Piatak M, Grill LK: Rapid high-level expression of biologically active α-trichosanthin in transfected plants by an RNA viral vector. Proc Natl Acad Sci USA 90, 427-430 (1993)
6. Hamamoto H, Sugiyama Y, Nakagawa N, Hashida E, Matsunaga Y, Takemoto S, Watanabe Y and Okada Y: A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato. Bio/Technology 11, 930-932 (1993)
7. Hiatt A, Cafferkey R and Bowdish K: Production of antibodies in transgenic plants. Nature 342, 76-78 (1989)
8. Ma JKC, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd, Mostov K, Wang K, Lehner T: Generation and assembly of secretory antibodies in plants. Science 268, 716-719 (1995)
9. Conrad U and Fiedler U: Expression of engineered antibodies in plant cells. Plant Mol Biol 26, 1023-1030 (1994)
10. Ma JKC and Hein MB: Immunotherapeutic potential of antibodies produced in plants. Trend in Biotech 13, 522-527 (1995)
11. Thanavala T, Yang YF, Lyons P, Mason HS and Arntzen C: Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA 92, 3358-3361 (1995)
12. Tsuda S, Yoshioka K, Tanaka T, Iwata A, Yoshikawa A, Watanabe Y and Okada Y: The application of the human hepatitis B virus core antigen from transgenic tobacco plants for serological diagnosis. Vox Sang in press
13. Haq TA, Mason HS, Clements JD and Arntzen CJ: Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science 268, 714-716 (1995)
14. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK and Arntzen CJ: Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93, 5335-5340 (1996)
15. Richter L, Mason HS and Arntzen CJ: Transgenic plants created for oral immunization against diarrheal diseases. J Travel Med 3, 52-56 (1996)
16. Sugiyama Y, Hamamoto H, Takemoto S, Watanabe Y and Okada Y: Systemic production of foreign peptides on the particle surface of tobacco mosaic virus. FEBS Lett 359, 247 -250 (1995)
17. Turpin TH, Reinl SJ, Charoenivt Y, Hoffman SL, Fallarme V and Grill LK: Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Bio/Technology 13, 53-57 (1995)
18. Fitchen J, Beachy RN, Hein MB: Plant virus expressing hybrid coat protein and added murine epitope elicits autoantibody response. Vaccine 13, 1051-1057 (1995)
19. Dalsgaard K, Uttenthal A, Jones TD, Xu F, Merryweather A, Hamilton WDO, Langeveld JPM, Boshuizen RS, Kamstrup S, Lomonossoff GP et al: Plant-derived vaccine protects target animals against a viral desease. Nature Biotechnology 15, 248-252 (1997)
20. McLain L, Porta C, Lomonossoff GP, Durrani Z and Dimmock NJ: Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus. AIDS Research and Human Retroviruses 11, 327-334 (1995)
21. Joelson T, Alerblom L, Oxelfelt P, Standberg B, Tomenius K and Morris JT: Presentation of a foreign peptide on the surface of tomato bushy stunt virus. J Gen Virol 78, 1213-1217 (1997)
22. Cruz SS, Chapman S, Roberts AG, Roberts IM, Prior AM and Oprka KJ: Aseembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc Natl Acad Sci USA 93, 6286-6290 (1996)
23. Mason HS and Arntzen CJ: Transgenic plants as vaccine production systems. Trend in Biotech 13, 388-392 (1995)